THE QUESTION. Among the 48 vaccines against the coronavirus currently being tested in humans, two in particular have a head start: that developed by the biotechnology company Moderna Therapeutics, and that of the American pharmaceutical giant Pfizer (developed with the German company BioNTech).
In both cases, it is a vaccine of a new kind said “to messenger RNA“. A fairly recent technology that involves injecting part of the genetic material of a virus into the body to induce an immune response against the same virus. Presented in such a succinct manner, the technology may seem frightening to the general public: is there not a risk that this viral gene pool will mix with ours?
CHECKS. This idea is actually more science fiction than anything else. But to be convinced of this, it is useful to understand how our cells work. There are two types of genetics coding molecules which are